MarketPeel
Insider Trading Intelligence
Pricing
…
CE

Carl Anthony Evans

CNSP
DIRECTOR · CNS PHARMACEUTICALS, INC. · CIK 0001792582
FILING MIX · LIFETIME100%/0%
BUYS
10
SELLS
0
TOTAL VALUE
$11.0K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
147,094
AVG SELL PX
—
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Carl Anthony Evans, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+0.12%+1.86%-1.75%-1.75%—
14d1+100.00%+12.08%+2.62%+9.46%+9.46%—
30d1+100.00%+22.77%+4.83%+17.94%+17.94%—
60d1+100.00%+42.49%+7.07%+35.43%+35.43%—
90d1+0.00%-13.66%+2.60%-16.26%-16.26%—
180d1+0.00%-96.75%+11.50%-108.25%-108.25%—
1y1+0.00%-99.25%+24.60%-123.85%-123.85%—
2y1+0.00%-99.93%+43.69%-143.62%-143.62%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CNSP · 147,094 shares · as of Apr 8, 2024
044,64089,280133,919178,5592021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
FLOW · 10 buys / 0 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
17,500——129,594Apr 8, 2024Apr 10, 2024 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
17,500——147,094Apr 8, 2024Apr 10, 2024 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
33,333——112,094Feb 1, 2024Feb 5, 2024 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASE
33,333$0.30$10.0K33,458Feb 1, 2024Feb 5, 2024 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
33,333——78,761Feb 1, 2024Feb 5, 2024 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
68,961——74,914Sep 21, 2023Sep 25, 2023 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
39,475——45,428Sep 21, 2023Oct 12, 2023 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3,750$0.27$1.0K3,750Mar 8, 2022Mar 9, 2022 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,000——178,559Jul 15, 2021Jul 16, 2021 ↗View →
CNSP
CNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
46,559——146,559Jun 12, 2020Jun 16, 2020 ↗View →
Other insiders · CNSP
Loading peer insiders…
About this filer
CIK 0001792582
ROLE
Director
PRIMARY
CNSP
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001792582DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback